Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer.

BJU international - 1 Mar 2017

Zhang Ben Y, Riska Shaun M, Mahoney Douglas W, Costello Brian A, Kohli Rhea, Quevedo Jorge F, Cerhan James R, Kohli Manish

Abstract excerpt

OBJECTIVES: To evaluate the prognostic significance of germline variation in candidate genes in patients with castration-resistant prostate cancer (CRPC). METHODS: Germline DNA was extracted from peripheral blood mononuclear cells of patients with CRPC enrolled in a clinically annotated registry. Fourteen candidate genes implicated in either initiation or progression of prostate cancer were tagged using single...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Germ-Line Mutation

Share to Janus Kinase 2

Share to Prognosis

Share to Prostatic Neoplasms, Castration-Resistant

Share to Survival Rate

Source

Identifiers

PMID: 27410686
DOI: 10.1111/bju.13584

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer.PMID 27410686Read ↗

Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC).Semantic proximity Read ↗

Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival.Semantic proximity Read ↗

Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical OutcomeSemantic proximity Read ↗

Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer.Semantic proximity Read ↗

Germline Mutations in DNA Repair Genes in Patients With Metastatic Castration-resistant Prostate Cancer.Semantic proximity Read ↗

Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.Semantic proximity Read ↗

Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practiceSemantic proximity Read ↗

Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer.Semantic proximity Read ↗

Clinical Predictors of Germline DNA Damage Repair Gene Mutations in Patients with Advanced Prostate CancerSemantic proximity Read ↗

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.Semantic proximity Read ↗

Genome-wide association study of prostate cancer-specific survival.Semantic proximity Read ↗

Susceptibility loci associated with prostate cancer progression and mortality.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.